Update on rimonabant - A selective cannabinoid CB1 antagonist [1]

Steven T. Boyd, Bradley A Fremming

Research output: Contribution to journalLetter

3 Citations (Scopus)
Original languageEnglish (US)
Number of pages1
JournalAnnals of Pharmacotherapy
Volume40
Issue number5
DOIs
StatePublished - May 1 2006

Fingerprint

rimonabant
Piperidines
Pyrazoles
Cannabinoid Receptor Antagonists
Cannabinoid Receptor CB1
Dyslipidemias
Cardiovascular Diseases
Randomized Controlled Trials
Obesity

ASJC Scopus subject areas

  • Pharmacology (medical)
  • Pharmacology, Toxicology and Pharmaceutics(all)

Cite this

Update on rimonabant - A selective cannabinoid CB1 antagonist [1]. / Boyd, Steven T.; Fremming, Bradley A.

In: Annals of Pharmacotherapy, Vol. 40, No. 5, 01.05.2006.

Research output: Contribution to journalLetter

@article{2bf1035c7f1941beb73ecf7e799f7514,
title = "Update on rimonabant - A selective cannabinoid CB1 antagonist [1]",
author = "Boyd, {Steven T.} and Fremming, {Bradley A}",
year = "2006",
month = "5",
day = "1",
doi = "10.1345/aph.1G713",
language = "English (US)",
volume = "40",
journal = "Annals of Pharmacotherapy",
issn = "1060-0280",
publisher = "Harvey Whitney Books Company",
number = "5",

}

TY - JOUR

T1 - Update on rimonabant - A selective cannabinoid CB1 antagonist [1]

AU - Boyd, Steven T.

AU - Fremming, Bradley A

PY - 2006/5/1

Y1 - 2006/5/1

UR - http://www.scopus.com/inward/record.url?scp=33646791152&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33646791152&partnerID=8YFLogxK

U2 - 10.1345/aph.1G713

DO - 10.1345/aph.1G713

M3 - Letter

VL - 40

JO - Annals of Pharmacotherapy

JF - Annals of Pharmacotherapy

SN - 1060-0280

IS - 5

ER -